Crystalline organic-inorganic halide perovskite thin films and methods of preparation
09895714 ยท 2018-02-20
Assignee
Inventors
- David T. Moore (Ithaca, NY, US)
- Hiroaki Sai (Evanston, IL, US)
- Kwan Wee Tan (Singapore, SG)
- Lara A. Estroff (Dryden, NY)
- Ulrich B. Wiesner (Ithaca, NY, US)
Cpc classification
C23C18/1204
CHEMISTRY; METALLURGY
H10K85/50
ELECTRICITY
Y02P20/54
GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
H10K30/10
ELECTRICITY
International classification
C07C211/63
CHEMISTRY; METALLURGY
B05D3/00
PERFORMING OPERATIONS; TRANSPORTING
Abstract
A film comprising a crystalline halide perovskite composition having the following formula:
AMX.sub.3(1)
wherein: A is an organic cation selected from the group consisting of methylammonium, tetramethylammonium, formamidinium, and guanidinium; M is at least one divalent metal; and X is independently selected from halide atoms; wherein the crystalline film of the halide perovskite composition possesses at least one of an average grain size of at least 30 microns, substantial crystal orientation evidenced in an ordering parameter of at least 0.6, and a level of crystallinity of at least 90%. Methods for producing films of these halide perovskite compositions using ionic liquids instead of volatile organic solvents are also described herein.
Claims
1. A film comprising a crystalline halide perovskite composition having the following formula:
AMX.sub.3(1) wherein: A is an organic cation selected from the group consisting of methylammonium, tetramethylammonium, formamidinium, and guanidinium; M is at least one divalent metal; and X is independently selected from halide atoms; wherein the crystalline film of the halide perovskite composition possesses at least one of an average grain size of at least 30 microns, substantial crystal orientation evidenced in an ordering parameter of at least 0.6, and a level of crystallinity of at least 90%.
2. The film of claim 1, wherein the film of the crystalline halide perovskite composition possesses an average grain size of at least 30 microns.
3. The film of claim 1, wherein the film of the crystalline halide perovskite composition possesses an average grain size of at least 50 microns.
4. The film of claim 1, wherein the film of the crystalline halide perovskite composition possesses an average grain size of at least 100 microns.
5. The film of claim 1, wherein the at least one divalent metal is selected from lead, tin, and germanium.
6. The film of claim 1, wherein the film has a thickness of at least 200 nm.
7. A method for producing a film of a crystalline halide perovskite composition, the method comprising: i) forming a film of a perovskite precursor solution onto a substrate, the perovskite precursor solution comprising a) a metal-containing compound of the formula MX.sub.2, where M is at least one divalent metal and X is a monovalent anion; b) an organic salt of the formula AX, wherein A is selected from methylammonium, tetramethylammonium, formamidinium, and guanidinium, and X is independently selected from halide atoms; and c) an ionic liquid; wherein components a) and b) are dissolved in component c); and ii) annealing the film of the perovskite precursor solution at a temperature of at least 30? C. for a time period effective to convert perovskite precursor components in the perovskite precursor solution to a film of a crystalline halide perovskite composition having the following formula:
AMX.sub.3(1) wherein A, M, and X are as defined above; and wherein the crystalline film of the halide perovskite composition possesses at least one of an average grain size of at least 30 microns, substantial crystal orientation evidenced in an ordering parameter of at least 0.6, and a level of crystallinity of at least 90%.
8. The method of claim 7, wherein the at least one divalent metal (M) is selected from lead, tin, and germanium.
9. The method of claim 7, wherein the film of the crystalline halide perovskite composition has a thickness of at least 200 nm.
10. The method of claim 7, wherein the ionic liquid is selected from the group consisting of an alkylammonium ionic liquid, formamidinium ionic liquid, and guanidinium ionic liquid.
11. The method of claim 7, wherein the ionic liquid possesses a cation that is equivalent to the cation A in the organic salt.
12. The method of claim 7, wherein the ionic liquid possesses an anion other than halide.
13. The method of claim 7, wherein the ionic liquid possesses a carbon-containing anion.
14. The method of claim 7, wherein MX.sub.2 and AX in the precursor are present in a relative amount such that the ratio of M:X is about 1:3.
15. The method of claim 7, wherein a temperature of at least 30? C. and up to 150? C. is used in the annealing step (ii).
16. The method of claim 7, wherein the film of the crystalline halide perovskite composition possesses an average grain size of at least 30 microns.
17. The method of claim 7, wherein the film of the crystalline halide perovskite composition possesses an average grain size of at least 50 microns.
18. The method of claim 7, wherein the film of the crystalline halide perovskite composition possesses an average grain size of at least 100 microns.
19. The method of claim 7, further comprising removing the ionic liquid by rinsing said film of the crystalline halide perovskite composition with a solvent in which the ionic liquid is soluble.
Description
BRIEF DESCRIPTION OF THE FIGURES
(1)
(2)
DETAILED DESCRIPTION OF THE INVENTION
(3) In one aspect, the invention is directed to a crystalline film having a halide perovskite composition. The term crystalline, as used herein, generally refers to a polycrystalline structure, although a single-crystal structure is also considered herein. As well known in the art, a polycrystalline material possesses crystal grains, which can be characterized as having an average grain size. Particularly in the case of photovoltaic and other photoactive materials, a larger grain size is desirable since it generally provides improved photoelectric or photocatalytic properties. The conventional VOC process is known to produce halide perovskite films with an average grain size generally no greater than 10 microns (10 ?m). In contrast, the process described herein using ionic liquids instead of VOC solvents is generally capable of achieving an average grain size of at least or above 30 ?m. In different embodiments, the process described herein produces a perovskite polycrystalline film having an average grain size of about, at least, or above 30 ?m, 40 ?m, 50 ?m, 60 ?m, 70 ?m, 80 ?m, 90 ?m, 100 ?m, 120 ?m, 150 ?m, 180 ?m, 200 ?m, 220 ?m, 250 ?m, 280 ?m, or 300 ?m, or an average grain size within a range bounded by any two of the foregoing exemplary values. The term about, as used herein, generally indicates a deviation of no more than 10%, 5%, or 1% from a given value. Thus, the term about 100 ?m may indicate, within its broadest interpretation, a value in the range of 90-110 ?m.
(4) The crystalline film may alternatively or in addition be characterized by its level of crystal orientation, which may be quantified by the ordering parameter. As used herein, the term ordering parameter refers to the ratio of the majority crystal orientation over all crystal orientations. As a film becomes completely amorphous, the ordering parameter approaches zero (0). On the other end of the spectrum, as the film approaches a single-crystal structure, the ordering parameter approaches one (1). The process described herein is generally capable of achieving an ordering parameter of at least or above 0.6, 0.65, 0.7, 0.75, 0.8, 0.85, or 0.9.
(5) The crystalline film may alternatively or in addition be characterized by its level of crystallinity, which can be quantified as the ratio of the volume of the film having a crystalline structure over the total volume of the film. The process described herein is generally capable of achieving a level of crystallinity of at least or above 90%, 92%, 95%, 97%, or 99%, or even 100%.
(6) The crystalline film described herein has a halide perovskite composition according to the following formula:
AMX.sub.3(1)
(7) In the above Formula (1), A is an organic cation selected from one or a combination of two or more of methylammonium (CH.sub.3NH.sub.3.sup.+), tetramethylammonium ((CH.sub.3).sub.4N.sup.+), formamidinium (H.sub.2N?CHNH.sub.2.sup.+), and guanidinium (H.sub.2N?C(NH.sub.2).sub.2.sup.+) organic cations. In some embodiments, the organic cation A may or may not be partially substituted (i.e., typically up to or less than about 1, 5, 10, or 20 mol %) with a monovalent metal ion, such as an alkali metal, such as cesium (Cs.sup.+). In other embodiments, the perovskite crystal structure may be doped (e.g., by partial substitution of the organic cation A and/or the metal M) with a doping element, which may be, for example, an alkali metal (e.g., Li.sup.+, Na.sup.+, K.sup.+, Rb.sup.+, or Cs.sup.+), an alkaline earth metal (e.g., Mg.sup.+2, Ca.sup.+2, or Sr.sup.+2) or other divalent metal, such as provided below for M, but different from M (e.g., Sn.sup.+2, Zn.sup.+2, or Cd.sup.+2), or a Group 14 element, such as Sb, Ge, or Bi, typically in an amount of up to or less than about 1, 5, 10, or 20 mol % of the organic cation A or metal M. The variable M is at least one divalent (M.sup.+2) metal atom. The divalent metal (M) can be, for example, one or more divalent elements from Group 14 of the Periodic Table (e.g., divalent lead, tin, or germanium), one or more divalent transition metal elements from Groups 3-12 of the Periodic Table (e.g., divalent titanium, vanadium, chromium, manganese, iron, cobalt, nickel, copper, zinc, palladium, platinum, and cadmium), and/or one or more divalent alkaline earth elements (e.g., divalent magnesium, calcium, strontium, and barium). The variable X is independently selected from one or a combination of halide atoms, wherein the halide atom (X) may be, for example, fluoride (F.sup.?), chloride (Cl.sup.?), bromide (Br.sup.?), and/or iodide (I.sup.?).
(8) The crystalline perovskite film described herein can have any suitable film thickness, but more typically has a film thickness of at least 200 nm. In different embodiments, the perovskite film has a film thickness of about, at least, above, up to, or less than, for example, 200 nm, 300 nm, 400 nm, 500 nm, 1000 nm (1 ?m), 2 ?m, 3 ?m, 4 ?m, 5 ?m, 6 ?m, 7 ?m, 8 ?m, 9 ?m, or 10 ?m.
(9) In another aspect, the invention is directed to a method for producing the above-described organic-inorganic halide perovskite film. In the method, a perovskite precursor solution (i.e., precursor solution) is deposited onto a substrate as a film, and the film of precursor solution is annealed at a temperature of at least 30? C. for a time period effective to convert the precursor solution to a film of a crystalline halide perovskite composition having the composition of Formula (1), as discussed above.
(10) The precursor solution includes: a) a metal-containing compound of the formula MX.sub.2, where M is at least one divalent metal, as described above, and X is a monovalent anion; b) an organic salt of the formula AX, wherein A is selected from methylammonium, tetramethylammonium, formamidinium, and guanidinium, and X is independently selected from halide atoms; and c) an ionic liquid. In the precursor solution, components a) and b) are completely dissolved in component c), the ionic liquid.
(11) In the metal-containing species MX.sub.2, the anionic species X can be any anionic species, including halide species X. In the event the anionic species X is not a halide species, the anionic species X is any anionic species capable of being replaced with a halide species under the annealing conditions used in the method. Some examples of anionic species X, other than halide species, include formate, acetate, propionate, carbonate, nitrate, sulfate, thiosulfate, oxalate, triflate, cyanate, thiocyanate, acetylacetonate, and 2-ethylhexanoate. Some examples of metal-containing species MX.sub.2 include lead(II) fluoride, lead(II) chloride, lead(II) bromide, lead(II) iodide, lead(II) acetate, lead(II) carbonate, lead(II) nitrate, lead(II) sulfate, lead(II) oxalate, lead(II) triflate, lead(II) thiocyanate, lead(II) acetylacetonate, lead(II) 2-ethylhexanoate, tin(II) fluoride, tin(II) chloride, tin(II) bromide, tin(II) iodide, tin(II) acetate, tin(II) carbonate, tin(II) nitrate, tin(II) sulfate, tin(II) oxalate, tin(II) triflate, tin(II) thiocyanate, tin(II) acetylacetonate, tin(II) 2-ethylhexanoate, germanium(II) chloride, germanium(II) bromide, germanium (II) iodide, titanium(II) chloride, titanium(II) bromide, titanium(II) iodide, titanium(II) acetate, magnesium fluoride, magnesium chloride, magnesium bromide, magnesium iodide, magnesium acetate, magnesium sulfate, calcium fluoride, calcium chloride, calcium bromide, calcium iodide, calcium acetate, and calcium sulfate.
(12) In the organic salt of the formula AX, the cation species A is selected from methylammonium, tetramethylammonium, formamidinium, and guanidinium, and X is a halide atom. Some examples of organic salts AX include methylammonium fluoride, methylammonium chloride, methylammonium bromide, methylammonium iodide, tetramethylammonium fluoride, tetramethylammonium chloride, tetramethylammonium bromide, tetramethylammonium iodide, formamidinium chloride, formamidinium bromide, formamidinium iodide, guanidinium fluoride, guanidinium chloride, guanidinium bromide, and guanidinium iodide.
(13) In the precursor solution, MX.sub.2 and AX in the precursor are generally present in such relative amount that provides a molar ratio of M:X of about 1:3. In the case where X is a halide (X), which corresponds with MX.sub.2 being MX.sub.2, then a M:X molar ratio of about 1:3 can be provided by a 1:1 molar ratio of MX.sub.2:AX. In the case where X is non-halide (e.g., acetate), then a M:X molar ratio of about 1:3 can be provided by a 1:3 molar ratio of MX.sub.2:AX.
(14) The term ionic liquid, as used herein, refers to any of the widely known ionic compounds that behave as liquids below 100? C., and more typically, at or near room temperature (e.g., 15, 20, 25, 30, 35, 40, 45, or 50? C.) without being dissolved in another solvent. The ionic liquid can be conveniently described by the formula Y.sup.+W.sup.?, wherein Y.sup.+ is a cationic component of the ionic liquid and W.sup.? is an anionic component (counterion) of the ionic liquid, which can be any of the counterions well known in the art and as provided above, as long as the combination of Y.sup.+ and W.sup.? result in an ionic liquid. In the formula Y.sup.+W.sup.?, the cationic component (Y.sup.+) can have any valency of positive charge, and the anionic component (W.sup.?) can have any valency of negative charge, provided that the charge contributions from the cationic and anionic portions are counterbalanced to ensure charge neutrality. Thus, the ionic liquid can be more generically described by the formula (Y.sup.+a).sub.y(W.sup.?b).sub.x, wherein the variables a and b are, independently, non-zero integers, and the subscript variables x and y are, independently, non-zero integers, such that a.y=b.x. The foregoing generic formula encompasses numerous possible sub-formulas, such as, for example, (Y.sup.+)(W.sup.?), (Y.sup.+2)(W.sup.?).sub.2, (Y.sup.+).sub.2(W.sup.?2), (Y.sup.+2).sub.2(W.sup.?2).sub.2, (Y.sup.+3)(W.sup.?).sub.3, (Y.sup.+).sub.3(W.sup.?3), (Y.sup.+3).sub.2(W.sup.?2).sub.3, and (Y.sup.+2).sub.3(W.sup.?3).sub.2.
(15) The ionic liquid contains a cation (Y.sup.+) that may be the same or different than the cation (A) in the organic salt. In some embodiments, the ionic liquid contains a cation (Y.sup.+) selected from methylammonium, tetramethylammonium, formamidinium, and guanidinium anionic species, as provided for the cation (A) in the organic salt, and which may be the same or different than the cation (A) in the organic salt. In the case where the cation (Y.sup.+) in the ionic liquid is selected from methylammonium, tetramethylammonium, formamidinium, and guanidinium anionic species, and is different than the cation (A) in the organic salt, the cation (Y.sup.+) in the ionic liquid is capable of exchanging with the cation (A) in the organic salt during the annealing process. Thus, in the latter embodiment, the cation (A) in the produced perovskite composition according to Formula (1) may be a mixture of two cationic species selected from methylammonium, tetramethylammonium, formamidinium, and guanidinium depending on the level of cation exchange between the organic salt and ionic liquid. In the event that the ionic liquid includes a cation (Y.sup.+) that is not selected from methylammonium, tetramethylammonium, formamidinium, and guanidinium (e.g., Y.sup.+ being dimethylammonium, trimethylammonium, ethylammonium, or an N-alkyl formamidinium or guanidinium derivative), exchange is not expected to occur between the cation (A) in the organic salt and Y.sup.+ of the ionic liquid during the annealing process since Y.sup.+ in this case would not be expected to fit into the perovskite structure according to Formula (1). A particular benefit of using an ionic liquid having a cation equivalent to the cation in the organic salt is that the diffusion of the cation out of the perovskite can be suppressed by Le Chatelier's principle, thereby further minimizing decomposition.
(16) The anion (W.sup.?) of the ionic liquid is any counterion which, when associated with a cationic component (Y.sup.+), permits the resulting ionic compound to behave as an ionic liquid. As known in the art, the composition and structure of the counteranion strongly affects the properties (e.g., melting point, volatility, stability, viscosity, hydrophobicity, and so on) of the ionic liquid.
(17) In one embodiment, the anion of the ionic liquid is inorganic. Some examples of such anions include fluoride, chloride, bromide, iodide, hexachlorophosphate (PCl.sub.6.sup.?), bifluoride (HF.sub.2.sup.?), hexafluorophosphate (PF.sub.6.sup.?), fluorophosphate (PO.sub.3F.sup.2?), tetrafluoroborate (BF.sub.4), aluminum fluorides (e.g., AlF.sub.4.sup.?), hexafluoroarsenate (AsF.sub.6.sup.?), hexafluoroantimonate (SbF.sub.6.sup.?), perchlorate, chlorate, chlorite, cyanate, isocyanate, thiocyanate, isothiocyanate, perbromate, bromate, bromite, periodate, iodate, carbonate, bicarbonate, dicyanamide (i.e., N(CN).sub.2.sup.?), tricyanamide (i.e., N(CN).sub.3.sup.?), aluminum chlorides (e.g., Al.sub.2Cl.sub.7.sup.? and AlCl.sub.4.sup.?), aluminum bromides (e.g., AlBr.sub.4.sup.?), nitrate, nitrite, sulfate, sulfite, hydrogensulfate, hydrogensulfite, phosphate, hydrogenphosphate (HPO.sub.4.sup.2?), dihydrogenphosphate (H.sub.2PO.sub.4.sup.?), phosphite, arsenate, antimonate, selenate, tellurate, tungstate, molybdate, chromate, silicate, the borates (e.g., borate, diborate, triborate, tetraborate), anionic borane and carborane clusters (e.g., B.sub.10H.sub.10.sup.2? and B.sub.12H.sub.12.sup.2?), perrhenate, permanganate, ruthenate, perruthenate, and the polyoxometallates. In some embodiments, any one or more classes or specific types of inorganic anions described above are excluded from the ionic liquid. For example, in some embodiments, the ionic liquid possesses an anion other than a halide species.
(18) In another embodiment, the anion of the ionic liquid is organic by including carbon and at least one carbon-hydrogen or carbon-fluorine bond. Some examples of such anions include the carboxylates (e.g., formate, acetate, propionate, butyrate, valerate, lactate, pyruvate, oxalate, malonate, glutarate, adipate, decanoate, salicylate, ibuprofenate, and the like), the sulfonates (e.g., CH.sub.3SO.sub.3.sup.?, CH.sub.3CH.sub.2SO.sub.3.sup.?, CH.sub.3(CH.sub.2).sub.2SO.sub.3.sup.?, benzenesulfonate, toluenesulfonate, dodecylbenzenesulfonate, docusate, and the like), the alkoxides (e.g., methoxide, ethoxide, isopropoxide, phenoxide, and glycolate), the amides (e.g., dimethylamide and diisopropylamide), diketonates (e.g., acetylacetonate), the organoborates (e.g., BR.sub.1R.sub.2R.sub.3R.sub.4.sup.?, wherein R.sub.1, R.sub.2, R.sub.3, R.sub.4 are typically hydrocarbon groups containing 1 to 6 carbon atoms), the alkylsulfates (e.g., diethylsulfate), alkylphosphates (e.g., ethylphosphate or diethylphosphate), the phosphinates (e.g., bis-(2,4,4-trimethylpentyl)phosphinate), the fluorosulfonates (e.g., CF.sub.3SO.sub.3.sup.?, CF.sub.3CF.sub.2SO.sub.3.sup.?, CF.sub.3(CF.sub.2).sub.2SO.sub.3.sup.?, CHF.sub.2CF.sub.2SO.sub.3.sup.?, and the like), the fluoroalkoxides (e.g., CF.sub.3O.sup.?, CF.sub.3CH.sub.2O.sup.?, CF.sub.3CF.sub.2O.sup.?, and pentafluorophenolate), the fluorocarboxylates (e.g., trifluoroacetate and pentafluoropropionate), and the fluorosulfonylimides (e.g., (CF.sub.3SO.sub.2).sub.2N.sup.?). In some embodiments, any one or more classes or specific types of organic anions described above are excluded from the ionic liquid.
(19) In a particular set of embodiments, the ionic liquid is an alkylammonium ionic liquid. The alkylammonium ionic liquids are well known in the art, as evidenced by, for example, M. Anouti et al., J. Phys. Chem. B, 112, 31, pp. 9406-9411 (2008) and Greaves et al., J. Phys. Chem. B, 112, 3, pp. 896-905 (2008), the contents of which are herein incorporated by reference in their entirety. The cationic component of the alkylammonium ionic liquid may be, for example, methylammonium, dimethylammonium, trimethylammonium, tetramethylammonium, ethylammonium, diethylammonium, triethylammonium, tetraethylammonium, ethyltrimethylammonium, diethyldimethylammonium, triethylmethylammonium, n-propylammonium, n-propyltrimethylammonium, isopropylammonium, n-butylammonium, n-butyltrimethylammonium, n-butylmethylammonium, di-(n-butyl)dimethylammonium, tri-(n-butyl)methylammonium, n-pentylammonium, n-pentyltrimethylammonium, tri-(n-pentyl)methylammonium, n-hexylammonium, n-hexyltrimethylammonium, tri-(n-hexyl)methylammonium, n-heptylammonium, n-heptyltrimethylammonium, tri-(n-heptyl)methylammonium, n-octylammonium, n-octyltrimethylammonium, tri-(n-octyl)methylammonium, benzyltrimethylammonium, choline, 2-hydroxyethylammonium, and allylammonium. In some embodiments, any one or more cationic species described above are excluded from the ionic liquid.
(20) In some embodiments, the cationic component (Y.sup.+) of the ionic liquid contains a positively-charged heterocyclic ring. Such ionic liquids are well known in the art. In a first embodiment, the positively-charged heterocyclic ring includes a positively-charged ring nitrogen atom. The heterocyclic ring having a positively-charged ring nitrogen atom can be monocyclic, bicyclic, tricyclic, or a higher cyclic (polycyclic) ring system. Some examples of a heterocyclic ring having a positively-charged ring nitrogen atom include imidazolium, pyridinium, pyrazinium, pyrrolidinium, piperidinium, piperazinium, morpholinium, pyrrolium, pyrazolium, pyrimidinium, triazolium, oxazolium, thiazolium, triazinium, and cyclic guanidinium rings. In some embodiments, the cationic component (Y.sup.+) of the ionic liquid is not a heterocyclic species, or any one or more of the above heterocyclic rings may be excluded from the ionic liquid.
(21) In some embodiments, the cationic component (Y.sup.+) of the ionic liquid is a phosphonium or sulfonium species. Such ionic liquids are also well known in the art. Some examples of phosphonium species include tetramethylphosphonium, tetraethylphosphonium, tetrapropylphosphonium, tetrabutylphosphonium, tetrapentylphosphonium, tetrahexylphosphonium, tetraheptylphosphonium, tetraoctylphosphonium, tetraphenylphosphonium, ethyltrimethylphosphonium, and dibutyldimethylphosphonium. Some examples of sulfonium species include trimethylsulfonium, dimethylethylsulfonium, diethylmethylsulfonium, triethylsulfonium, dimethylpropylsulfonium, dipropylmethylsulfonium, tripropylsulfonium, dimethylbutylsulfonium, dibutylmethylsulfonium, and tributylsulfonium.
(22) Generally, the ionic liquid used in the process described herein is used in the substantial or complete absence of a non-ionic liquid, wherein a non-ionic liquid is also referred to herein as a VOC solvent (relative to an ionic liquid). The non-ionic liquid being excluded includes any of the organic or inorganic non-ionic solvents known in the art, all of which are known to be significantly more volatile than an ionic liquid. Some examples of organic solvents that may be excluded from the instant process include dimethylformamide, dimethylsulfoxide, acetonitrile, propionitrile, acetone, ethylacetate, methylene chloride, chloroform, methanol, ethanol, isopropanol, ethylene glycol, diethyl ether, glyme, diglyme, propylene carbonate, N-methyl-2-pyrrolidinone, gamma-butyrolactone, tetrahydrofuran, benzene, toluene, decalin, and hexamethylphosphoramide. Some examples of inorganic solvents that may be excluded from the instant process include water, carbon disulfide, supercritical carbon dioxide, carbon tetrachloride, and sulfuryl chloride fluoride. By being excluded from the instant process, the volatile solvent is excluded at least through the complete conversion of precursor components to the crystalline halide perovskite film. Thereafter, a volatile (non-ionic) solvent may or may not be used for further processing, such as for removing the ionic liquid from the perovskite film.
(23) The precursor solution containing the above components (i.e., metal-containing compound MX.sub.2, organic salt AX, and ionic liquid) is deposited onto a substrate as a precursor film. The precursor solution can be deposited by any of the processes well known in the art for depositing liquid films. Some examples of film deposition processes include spin-coating, drag-coating, spray-coating, and dip-coating. The substrate on which the precursor solution is placed can be any useful substrate known in the art, including functional substrates and sacrificial substrates. The substrate can be any substrate that is non-reactive with the precursor components, is suitably robust to withstand the elevated temperature of the annealing step, and is suitable for integration into a photoactive device. The choice of functional substrate is dependent on the end-use application. In some embodiments, the substrate is inorganic, such as, for example, silicon (Si), a metal (e.g., Al, Co, Ni, Cu, Ti, Zn, Pt, Au, Ru, Mo, W, Ta, or Rh, stainless steel, a metal alloy, or combination thereof), a metal oxide (e.g., glass or a ceramic material, such as F-doped indium tin oxide), a metal nitride (e.g., TaN), a metal carbide, a metal silicide, or a metal boride. In other embodiments, the substrate is organic, such as a rigid or flexible heat-resistant plastic or polymer film, or a combination thereof, or multilayer composite thereof. Some of these substrates, such as molybdenum-coated glass and flexible plastic or polymeric film, are particularly suitable for use in photovoltaic applications. The photovoltaic substrate can be, for example, an absorber layer, emitter layer, or transmitter layer useful in a photovoltaic device. The substrate may be porous or non-porous depending on the end use of the perovskite film.
(24) After depositing the precursor solution as a film on a substrate, the precursor film (while on the substrate) is subjected to an annealing step. The film of the perovskite precursor solution is annealed at a temperature of at least or above 30? C. for a time period effective to convert the perovskite precursor components in the perovskite precursor solution to a film of a crystalline halide perovskite within the scope of Formula (1) above. In different embodiments, the annealing step employs a temperature of about, at least, above, up to, or less than 40? C., 50? C., 60? C., 70? C., 80? C., 90? C., 100? C., 110? C., 120? C., 130? C., 140? C., 150? C., 160? C., 170? C., 180? C., 190? C., or 200? C., or a temperature within a range bounded by any two of the foregoing values. As discussed above, unlike conventional processes using volatile solvents, the instant process using ionic liquids permits the use of a much wider range of temperatures, with the maximum temperature primarily limited by the boiling point or decomposition temperature of the ionic liquid and the decomposition temperature of the halide perovskite. In various embodiments, the annealing step of the present invention may employ a temperature in the range of, for example, 30-200? C., 30-180? C., 30-150? C., 30-140? C., 30-130? C., 30-120? C., 30-110? C., or 30-100? C.
(25) As the ionic liquid is substantially non-volatile, even at elevated temperatures, the annealing process described herein may subject the precursor film to an elevated temperature, such as any of the temperatures provided above, over a suitable amount of time without limitation. Depending on the temperature used and the nature of the precursor species, the period of time may be, for example, at least 10, 20, 30, 60, 90, or 120 minutes and up to, for example, 180, 240, 360, 480, 600, 1200, 1500, or 1800 minutes.
(26) After the conversion to the crystalline halide perovskite is complete in the annealing step, the ionic liquid can be conveniently removed from the perovskite film by rinsing the perovskite film with a solvent in which the ionic liquid is soluble. The solvent may be, for example, any of the non-ionic liquid solvents provided above. The residual solvent may then be removed by simple air drying or by inert gas flow (e.g., nitrogen), particularly in the case of low-boiling solvents (e.g., b.p. of up to 100? C.), and/or by application of a sufficiently elevated temperature as a post-annealing step, particularly for high-boiling solvents (e.g., b.p. over 100? C.). In another embodiment, the ionic liquid is removed by heating it at or near its boiling point for a suitable period of time. If desired, a vacuum may be applied to facilitate the removal of the ionic liquid or to employ a lower temperature for its removal.
(27) In some embodiments, the perovskite film is also covered by a top layer of a solid material, such as a metal or metal oxide, in order to sandwich the perovskite film between two layers of material. The layers may serve to, for example, protect the perovskite film from oxidative degradation or provide a means of electrical conduction. In some embodiments, the substrate and/or top layer is electrically conductive or photoactive to work in concert with the perovskite film. The substrate and/or top layer may also be porous or include one or more windows to permit contact of a gas or liquid with the perovskite film, in the event the perovskite film is used as a photocatalyst or in a photoelectrochemical device.
(28) The above-described crystalline perovskite films are useful in a variety of photoactive and related applications. The perovskite films can thus be integrated into any of a variety of devices directed to such applications. The perovskite films may be integrated into, for example, a photovoltaic device (e.g., solar cell or panel), light-emitting diode, photoluminescent device, laser, photodetector, x-ray detector, photocatalytic device, photoelectrochemical device, or thermoelectric device. The integration of such films into such devices is well known in the art.
(29) Examples have been set forth below for the purpose of illustration and to describe the best mode of the invention at the present time. However, the scope of this invention is not to be in any way limited by the examples set forth herein.
EXAMPLES
Preparation of a Thin Film of (CH3NH3)PbI3 Perovskite from Methylammonium Formate (CH3NH3+HCOO?) Ionic Liquid
(30) Methylammonium Formate (CH.sub.3NH.sub.3.sup.+HCOO.sup.?) Synthesis
(31) To synthesize methylammonium formate ionic liquid, 25 mL of methylamine at 33% in ethanol and 10 mL absolute ethanol were added to a round bottom flask in an ice bath and placed under nitrogen flow on a Schlenk line. 6 mL of 88% formic acid was mixed with 25 mL of methanol and loaded into a 60 mL syringe. The formic acid solution was added dropwise to the methylamine solution using a syringe pump at a rate of 2-3 drops per second through a septum to maintain the seal in the round bottom flask. The reaction solution was stirred slowly during the addition of the formic acid solution. After the complete addition of the formic acid, the solution was stirred for an additional 1 hour, then the flask was placed under mild vacuum (?100 mTorr) for 24 hours. During the vacuum period, the ice bath was replenished periodically to maintain the temperature near 0? C. At the end of 24 hours, the temperature was raised to room temperature by removing the ice bath while maintaining vacuum; slow stirring was restored once the viscosity of the reaction product would allow for it. The reaction product was slowly stirred at room temperature for 60 minutes, at which point the solution was a clear viscous liquid.
(32) Preparation of Methylammonium Iodide (CH.sub.3NH.sub.3.sup.+I.sup.?) Organic Salt
(33) Methylammonium iodide was prepared as previously published (Lee et al., Science, 2012, 338, 643-647) and stored in a desiccator.
(34) Substrate Preparation
(35) Silicon or glass substrates were cleaned by sequential sonication in acetone and then isopropyl alcohol (IPA) for 5 minutes followed by rinsing with IPA and deionized (DI) water, followed by UV-ozone (UVO) cleaning for 5 minutes. Directly prior to spin-coating, the substrates were rinsed with IPA and DI water, dried under nitrogen flow, and cleaned with UVO for 1-2 minutes.
(36) Precursor Film Preparation
(37) A 30 wt % solution of PbI.sub.2 and methylammonium iodide in a 1:1 molar ratio was prepared in air by dissolving the two components in methylammonium formate ionic liquid and stirring at low speed overnight. Spin-cast films were made by depositing ?40 ?L of the 30 wt % solution and spinning at 2000 rpm for 30 seconds. Drag-coated films were made by depositing 3-5 ?L of 30 wt % solution on a substrate, then doctor blading, by hand, with a razor blade; film thickness was controlled by using Kapton tape of various thicknesses to control the blade height. Generally, the film thickness was approximately in the range of 500-700 nm.
(38) Annealing of the Precursor Film to Produce a Crystalline Film of (CH.sub.3NH.sub.3)PbI.sub.3
(39) Upon completion of the deposition, the substrates coated with precursor films were immediately placed on a preheated stage at the annealing temperature. After annealing, the films were allowed to cool for several minutes, and residual methylammonium formate ionic liquid was removed by submersion of the film in butanol for two minutes followed by rinsing with freshly dried butanol. After rinsing, residual butanol was removed by nitrogen flow followed by heating on a hot plate at 130? C. for 30 seconds. Note: the films used for in situ WAXS characterization did not undergo the rinsing step as the data was collected during film formation. As verified by XRD, SEM and UV-Vis absorption before and after the rinse, no changes were observed in the films due to the rinsing step.
(40) Characterization of the Perovskite Film
(41) The evolution of the crystal growth was determined by in situ synchrotron wide angle X-ray scattering (WAXS) during the annealing process.
(42) In further experiments, several different films were prepared and subjected to a variety of substantially different post-deposition annealing protocols.
(43) The success at bypassing a crystalline intermediate and decoupling the crystallization time from the temperature is of most value if it maintains or surpasses the level of film quality that has already been achieved by other methods.
(44) Reference films shown in
(45) In conclusion, using methylammonium formate as a representative ionic liquid, the above results demonstrate an improved process for producing high-quality crystalline thin films of (CH.sub.3NH.sub.3)PbI.sub.3 without an intermediate phase or perovskite decomposition over a broad range of annealing temperatures and processing times. The process results in films with superior coverage, uniformity, and large crystal domains that are highly oriented. The absence of an intermediate also permits the application of well-known solution-based methods for controlling both nucleation and growth.
(46) While there have been shown and described what are at present considered the preferred embodiments of the invention, those skilled in the art may make various changes and modifications which remain within the scope of the invention defined by the appended claims.